Published in Mucosal Immunol on July 02, 2008
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55
Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev (2012) 1.33
Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer (2011) 1.24
Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma. Gynecol Oncol (2012) 1.15
Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11
Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth. BMC Immunol (2010) 1.10
Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression. Clin Cancer Res (2012) 0.98
Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study. Int J Cancer (2013) 0.96
Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients. Nat Commun (2014) 0.95
New Insights into IDO Biology in Bacterial and Viral Infections. Front Immunol (2014) 0.92
Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7. J Invest Dermatol (2013) 0.92
HPV infection: immunological aspects and their utility in future therapy. Infect Dis Obstet Gynecol (2013) 0.89
New Approaches to Immunotherapy for HPV Associated Cancers. Cancers (Basel) (2011) 0.89
HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models. Immun Inflamm Dis (2014) 0.88
Immunotherapy of human papilloma virus induced disease. Open Virol J (2012) 0.83
Vaginal drug delivery for the localised treatment of cervical cancer. Drug Deliv Transl Res (2017) 0.83
Improving the efficiency of image guided brachytherapy in cervical cancer. J Contemp Brachytherapy (2016) 0.82
Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival. Oncoimmunology (2015) 0.81
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3. Oncoimmunology (2015) 0.80
Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. Immunology (2015) 0.79
Interferon regulatory factor (IRF)-1 is a master regulator of the cross talk between macrophages and L929 fibrosarcoma cells for nitric oxide dependent tumoricidal activity. PLoS One (2015) 0.79
Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol Lett (2015) 0.79
Pharmacologic Management of Advanced Cervical Cancer: Antiangiogenesis Therapy and Immunotherapeutic Considerations. Drugs (2015) 0.78
Polymorphisms in immune mediators associate with risk of cervical cancer. Gynecol Oncol (2014) 0.78
Effects of the levonorgestrel-releasing intrauterine device on the immune microenvironment of the human cervix and endometrium. Am J Reprod Immunol (2016) 0.78
[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy. Radiat Oncol (2016) 0.77
Soil-Transmitted Helminth Infections Are Associated With an Increase in Human Papillomavirus Prevalence and a T-Helper Type 2 Cytokine Signature in Cervical Fluids. J Infect Dis (2015) 0.77
Tumour virus vaccines: hepatitis B virus and human papillomavirus. Philos Trans R Soc Lond B Biol Sci (2017) 0.76
In vivo effects of nonoxynol-9 on endometrial immune cell populations. J Acquir Immune Defic Syndr (2009) 0.76
Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia. Int J Clin Oncol (2014) 0.76
Chemokine binding protein vCCI attenuates vaccinia virus without affecting the cellular response elicited by immunization with a recombinant vaccinia vector carrying the HPV16 E7 gene. Viral Immunol (2012) 0.76
Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia. Diagn Pathol (2015) 0.76
[Gynecological cancers in patients with inflammatory rheumatic diseases]. Z Rheumatol (2016) 0.75
Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer. PLoS One (2017) 0.75
Interactions between polymorphisms in the 3'untranslated region of the cyclin dependent kinase 6 gene and the human papillomavirus infection, and risk of cervical precancerous lesions. Biomed Rep (2017) 0.75
Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility. Mucosal Immunol (2017) 0.75
Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA (2001) 4.26
Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol (1989) 2.36
Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study. BJOG (2013) 2.00
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology (2001) 1.78
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. Br J Cancer (2012) 1.64
Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res (2001) 1.34
Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med (2000) 1.34
Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.18
Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood (1999) 1.14
Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. J Clin Oncol (1987) 1.08
The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys (1999) 1.07
The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer (1999) 1.03
Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. Cancer Res (1990) 1.03
Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol (1988) 0.99
Preliminary evaluation of prostate cancer metastatic risk biomarkers. Int J Biol Markers (2005) 0.98
Effects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnically diverse population of healthy young men. J Clin Invest (1995) 0.98
Correlating Papanicolaou Smear, Colposcopic Impression, and Biopsy: Results from the Women's Interagency HIV Study. J Low Genit Tract Dis (2001) 0.97
Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys (1998) 0.95
Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology (2001) 0.94
Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials. J Urol (2006) 0.92
Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children. N Engl J Med (1983) 0.91
Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113. Leuk Res (1979) 0.91
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B. Blood (1984) 0.91
Erectile dysfunction after radiotherapy for prostate cancer: a model assessing the conflicting literature on dose-volume effects. Int J Impot Res (2013) 0.89
Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol (1996) 0.88
Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin. Biol Psychiatry (1993) 0.88
Detection of genetic changes in anal intraepithelial neoplasia (AIN) of HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr (2001) 0.85
Identification of a high-risk clinically localized prostate cancer subgroup receiving maximum benefit from whole-pelvic irradiation. Cancer J Sci Am (1999) 0.85
Atypical squamous cells of undetermined significance: management patterns at an academic medical center. Am J Obstet Gynecol (1998) 0.85
Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management. Int J Gynecol Cancer (2004) 0.84
Recent developments in understanding the immune response to human papilloma virus infection and cervical neoplasia. Oncol Nurs Forum (2000) 0.83
Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions. Oncogene (2006) 0.83
Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Leukemia (1993) 0.80
Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys (2001) 0.79
Intraoperative radiation therapy for high-risk pediatric neuroblastoma. Int J Radiat Oncol Biol Phys (2000) 0.79
Epithelial-stromal interactions modulating penetration of matrigel membranes by HPV 16-immortalized keratinocytes. J Invest Dermatol (1997) 0.79
What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer? Urology (2003) 0.79
Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse. Cancer (1986) 0.78
The impact of race on freedom from prostate-specific antigen failure in prostate cancer patients treated with definitive radiation therapy. Semin Urol Oncol (2000) 0.78
Chemoendocrine therapy vs chemotherapy alone for advanced breast cancer in postmenopausal women: preliminary report of a randomized study. Breast Cancer Res Treat (1983) 0.78
beta-Endorphin/beta-lipotropin immunoreactivity in endogenous depression. Effect of dexamethasone. Arch Gen Psychiatry (1986) 0.78
Follow-up of unsatisfactory Papanicolaou test results. JAMA (2000) 0.77
High-protein ascites in patients with the acquired immunodeficiency syndrome. Gastroenterology (1991) 0.77
Beta-lapachone inhibits proliferation and induces apoptosis in retinoblastoma cell lines. Eye (Lond) (2007) 0.77
Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study. Cancer Treat Rep (1984) 0.76
Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study. Cancer Treat Rep (1982) 0.76
Angiogenesis in histologically benign squamous mucosa is a sensitive marker for nearby cervical intraepithelial neoplasia. Angiogenesis (1998) 0.76
Angiogenesis in squamous cell carcinoma in situ and microinvasive carcinoma of the uterine cervix. Obstet Gynecol (1997) 0.76
Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer? J Clin Oncol (2000) 0.75
Impact of dose hot spots on spinal cord tolerance following stereotactic body radiotherapy: a generalized biological effective dose analysis. Technol Cancer Res Treat (2012) 0.75
Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study. Cancer Treat Rep (1982) 0.75
Angiogenesis in histologically benign squamous mucosa is a sensitive marker for nearby cervical intraepithelial neoplasia. J Low Genit Tract Dis (1999) 0.75
Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study. Cancer Treat Rep (1983) 0.75
The treatment of melanoma with m-AMSA. A Cancer and Leukemia Group B phase II study. Am J Clin Oncol (1984) 0.75
Atypical squamous cells of undetermined significance: management patterns at an academic medical center. J Low Genit Tract Dis (1999) 0.75
Terminal transferase expression in acute myeloid leukaemia: biology and prognosis. Br J Haematol (1991) 0.75
Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up. Leukemia (1988) 0.75
Experience with autologous bone marrow harvesting and transfusion of marrow-derived red cells. Transfusion (1992) 0.75
[Search for microsatellite instability in colorectal cancer: an effective way to detect HNPCC?]. Gastroenterol Clin Biol (2001) 0.75
Participants at the ASCCP 2000 Biennial Meeting adhere to published guidelines in their management of atypical squamous cells and atypical glandular cells on pap test. J Low Genit Tract Dis (2003) 0.75
Chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil compared to chemotherapy plus hormonal therapy with tamoxifen in the treatment of advanced breast cancer: an interim analysis. J Steroid Biochem (1985) 0.75
Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial. Cancer Treat Rep (1982) 0.75
Interrater Variability in Diagnosis of Cervical Biopsies from Women with HIV-1: Results from the Women's Interagency HIV Study. J Low Genit Tract Dis (2000) 0.75